Restructuring Within Biogen's Research Division In a strategic shift following a challenging year, Biogen’s newly appointed research leader, Jane Grogan, Ph.D., is implementing significant adjustments to the company's research team.…
The technological race between the United States and China intensifies as the U.S. imposes strict export controls on biotechnology. The Department of Commerce has implemented new rules aimed at safeguarding…
**Biotech firm Athira Pharma, located in the Seattle area, has reached a significant settlement of $4.07 million.** This resolution comes after allegations surfaced regarding violations of the False Claims Act,…
The biotechnology sector is gaining momentum as investors seek opportunities amidst changing interest rates. **Goldman Sachs has identified biotech stocks as a lucrative investment avenue, especially considering their intricate connection…